Results 71 to 80 of about 6,430 (232)

Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management

open access: yesMedComm, Volume 6, Issue 11, November 2025.
Thyroid cancer risk is influenced by both genetic and modifiable factors, including mutations, radiation exposure, lifestyle, and pre‐existing benign conditions. Diagnosis involves physical exams, ultrasound, scintigraphy, laboratory tests, and fine‐needle aspiration biopsy (FNAB).
Yu‐Dong Li   +3 more
wiley   +1 more source

Current and emerging treatment options for Graves’ hyperthyroidism

open access: yesTherapeutics and Clinical Risk Management, 2009
Prakash Abraham1, Shamasunder Acharya21Department of Endocrinology, Aberdeen Royal Infirmary, Aberdeen, UK; 2Department of Endocrinology, John Hunter Hospital, New Lambton NSW, AustraliaAbstract: Radioiodine, antithyroid drugs and surgery have been well ...
Prakash Abraham, Shamasunder Acharya
doaj  

Lymphocyte profile in patients with Grave’s disease depending on the degree of its compensation

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2018
Background. In Ukraine today, the main method for the treatment of Grave’s disease (GD) is the administration of antithyroid drugs in order to achieve euthyroidism.
O.A. Goncharova
doaj   +1 more source

Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions

open access: yesJournal of Evaluation in Clinical Practice, Volume 31, Issue 7, October 2025.
ABSTRACT Background Pharmacological therapy in older persons is inherently complex due to the interplay of age‐related physiological changes, multimorbidity, and polypharmacy. These factors increase the vulnerability of elderly patients to drug interactions and adverse drug reactions.
N. N. Ngcobo
wiley   +1 more source

Outcome of radioiodine therapy without, on or 3days off carbimazole: a prospective interventional three-group comparison [PDF]

open access: yes, 2018
Purpose: Carbimazole ameliorates hyperthyroidism but reduces radioiodine uptake and adversely affects the outcome of simultaneous radioiodine therapy.
Christ-Crain, Mirjam   +4 more
core  

A Scoping Review of Human Teratogens and Their Impact on the Developing Brain: A Contribution From the ConcePTION Project

open access: yesBirth Defects Research, Volume 117, Issue 9, September 2025.
ABSTRACT Certain medications, when used during pregnancy, are known to impact human prenatal development. Historically, little attention has been given to the impact of in utero exposure on the developing brain, despite the significance of known teratogen‐induced neurodevelopmental difficulties.
M. Bluett‐Duncan   +14 more
wiley   +1 more source

Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care [PDF]

open access: yes, 2001
Postpartum thyroiditis is a syndrome of transient or permanent thyroid dysfunction occurring in the first year after delivery and based on an autoimmune inflammation of the thyroid. The prevalence ranges from 5-7%.
Berghout, A. (Arie)   +2 more
core   +3 more sources

The Role of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: Enhancing Post‐Surgical Outcomes and Overcoming Relapse

open access: yesMedicine Advances, Volume 3, Issue 3, Page 205-208, September 2025.
Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that's usually detected at an advanced stage and has a high recurrence rate despite surgical resection, making treatment challenging. Although mitotane is still the only approved treatment, its poor effectiveness has raised interest in immunotherapy with immune checkpoint inhibitors (ICIs ...
Jawairya Muhammad Hussain   +5 more
wiley   +1 more source

Drug-Induced Neutropenia and Agranulocytosis

open access: yesБезопасность и риск фармакотерапии, 2020
Drug-induced neutropenia and agranulocytosis are serious and potentially life-threatening complications of pharmacotherapy. The aim of the review was to systematise and analyse scientific literature on the prevalence, risk factors, pathogenesis, clinical
O. D. Ostroumova   +3 more
doaj   +1 more source

Potential Antithyroid Agents-Ill: N-Arylformamidino-N-Arylthiocarbamides

open access: yes, 1981
Department of Chemistry, University of Roorkee, Roorkee-247 672 Surgical Research Laboratory, Institute of Medical Sciences, Banaras Hindu University, Varanasi-221 005 Manuscript received 12 June 1980, revised 30 September 1980, accepted 5 November 1980 Since thioureylene linkage of drugs exhibit certain desired effects required by an antithyroid drug,
J. S. UPADHYAYA, P. K. SRIVASTAVA
openaire   +1 more source

Home - About - Disclaimer - Privacy